James Darecca's Net Worth

$99.6 Thousand

Estimate Recalculated Jun 13, 2025 08:26PM EST

Who is James Darecca

James Darecca does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HAEMONETICS CORP, Actavis plc, TherapeuticsMD, Inc., Prestige Consumer Healthcare Inc., and Actavis, Inc..

SEC CIK

James Darecca's CIK is 0001583903

Past Insider Trading and Trends

2020 was James Darecca's most active year for acquiring shares with 5 total transactions. James Darecca's most active month to acquire stocks was the month of February. 2017 was James Darecca's most active year for disposing of shares, totalling 7 transactions. James Darecca's most active month to dispose stocks was the month of February. 2020 saw James Darecca paying a total of $699,956.24 for 1,609,611 shares, this is the most they've acquired in one year. In 2020 James Darecca cashed out on 20,213 shares for a total of $137,820.10, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

HAEMONETICS CORP

EVP, Chief Financial Officer
Updated May 21, 2024
Form 4
109.98%
14.20K
May 21, 2024
27.10K
Grant
May 17
Form 4
-5.58%
-763.00
$95.71
-$73.03K
May 17, 2024
12.91K
Tax
May 15 - May 16
Form 4
-3.06%
-432.00
$93.33
-$40.32K
May 06, 2024
13.67K
Tax
May 02
Form 4
130.37%
13.36K
$89.21
-$31.13K
May 17, 2023
23.60K
Grant
May 15 - May 16
Form 4
-4.03%
-430.00
$81.66
-$35.11K
May 04, 2023
10.25K
Tax
May 02
Form 4
270.03%
15.94K
May 18, 2022
21.84K
Grant
May 16
Form 4
19.73K
May 04, 2022
19.73K
Grant
May 02
Form 3
Apr 14, 2022
Showing 8 results

Allergan plc

SVP Chief Accounting Officer
Updated May 11, 2020
Form 4
-100.00%
-19.50K
May 11, 2020
Disposition
May 08
Form 4
-6.80%
-718.00
$191.95
-$137.82K
Mar 10, 2020
9.83K
Tax
Mar 06
Form 4
52.02%
3.61K
$193.84
$699.96K
Mar 04, 2020
10.55K
Grant
Mar 02
Form 4
-1.31%
-92.00
$191.17
-$17.59K
Jan 02, 2020
6.94K
Tax
Dec 31
Form 4
-6.29%
-472.00
$143.49
-$67.73K
Mar 11, 2019
7.03K
Tax
Mar 07 - Mar 08
Form 4
37.23%
2.04K
$137.51
$279.97K
Mar 08, 2019
7.51K
Grant
Mar 06
Form 4
-2.04%
-114.00
$139.12
-$15.86K
Mar 06, 2019
5.47K
Tax
Mar 04
Form 4/A
45.84%
1.83K
$153.22
$279.78K
Mar 06, 2019
5.81K
Grant
Mar 07
Form 4
-2.62%
-147.00
$133.66
-$19.65K
Jan 03, 2019
5.45K
Tax
Dec 31
Form 4
-1.39%
-79.00
$153.50
-$12.13K
Mar 09, 2018
5.60K
Tax
Mar 08
Form 4
39.33%
1.60K
$153.22
$245.61K
Mar 08, 2018
5.68K
Grant
Mar 07
Form 4
-3.46%
-146.00
$146.28
-$21.36K
Mar 06, 2018
4.08K
Tax
Mar 02 - Mar 05
Form 4
-2.31%
-100.00
$163.58
-$16.36K
Jan 02, 2018
4.22K
Tax
Dec 29
Form 4
Oct 30, 2017
4.32K
Options
Oct 26
Form 4
40.08%
1.01K
$239.52
$241.53K
Mar 09, 2017
3.52K
Grant
Mar 07 - Mar 08
Form 4
-5.20%
-138.00
$245.63
-$33.90K
Mar 07, 2017
2.52K
Tax
Mar 04 - Mar 05
Form 4
-3.35%
-92.00
$229.32
$33.48K
Feb 03, 2017
2.65K
Options
Feb 01
Form 4
57.38%
914.00
$284.43
$259.97K
May 12, 2016
2.51K
Grant
Mar 08
Form 4
31.11%
378.00
$295.70
-$23.06K
Mar 09, 2015
1.59K
Grant
Mar 05
Form 4
605.33%
2.05K
$296.14
$259.71K
Mar 06, 2015
2.38K
Grant
Mar 04
Form 4
6.77K
Jul 03, 2014
6.77K
Grant
Jul 01
Form 4
338.00
$197.05
$66.60K
May 13, 2014
338.00
Grant
May 09
Form 3
Oct 03, 2013
Showing 23 results

TherapeuticsMD, Inc.

Chief Financial Officer
Updated Aug 12, 2021
Form 4
-14.33%
-93.34K
$0.87
-$81.20K
Aug 12, 2021
558.16K
Sale
Aug 10 - Aug 12
Form 4
520.00K
Jul 02, 2021
520.00K
Grant
Jul 01
Form 4/A
803.00K
Aug 07, 2020
803.00K
Grant
Jun 18
Form 4
803.00K
Jun 19, 2020
803.00K
Grant
Jun 18
Form 3
Jun 04, 2020
Showing 5 results

Prestige Consumer Healthcare Inc.

Investor
Updated Aug 07, 2024
Form 4
95.95%
2.20K
Aug 07, 2024
4.50K
Grant
Aug 06
Form 4
2.29K
Aug 03, 2023
2.30K
Grant
Aug 01
Form 3
Aug 03, 2023
Showing 3 results

Actavis, Inc.

Chief Accounting Officer
Updated Aug 09, 2013
Form 3
Aug 09, 2013
Showing 1 results